Laguna HilLS, California – Sonendo Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the second generation of its Multisonic Ultracleaning System for root canal therapy. The system is designed to be a minimally-invasive, disruptive technology that utilizes multiple wavelengths of sound to clean the entire root canal system simultaneously.
The FDA clearance gives Sonendo the right to market the system within the United States. Sonendo plans a limited launch in 2014, noted Bjarne Bergheim, president and CEO.
“Our goal is to transform endodontics by improving the clinical quality and business performance of practices performing root canal therapy, and this FDA clearance has brought Sonendo one step closer to realizing this goal,” Bergheim said.
Source: Sonendo
Latest from Today's Medical Developments
- NextDent 300 MultiJet printer delivers a “Coming of Age for Digital Dentistry” at Evolution Dental Solutions
- Get recognized for bringing manufacturing back to North America
- Adaptive Coolant Flow improves energy efficiency
- VOLTAS opens coworking space for medical device manufacturers
- MEMS accelerometer for medical implants, wearables
- The compact, complex capabilities of photochemical etching
- Moticont introduces compact, linear voice coil motor
- Manufacturing technology orders reach record high in December 2025